[Peripherally inserted central venous catheter still not evaluated for clinical use. More scientific support is needed according to a literature study].
Intensivvårdskliniken, Länssjukhuset Ryhov, Jönköping. fredrik.hammarskjold@lj.se
Fredrik
F
Hammarskjöld
Niklas
N
Nielsen
Stig
S
Rödjer
Håkan
H
Pärsson
Ursula
U
Falkmer
Bo-Eric
BE
Malmvall
D000970:Antineoplastic Agents / Q000008:administration & dosage; D002405:Catheterization, Central Venous / Q000009:adverse effects / Q000379:methods*; D002406:Catheterization, Peripheral / Q000009:adverse effects / Q000379:methods*; D003362:Cost-Benefit Analysis; D004866:Equipment Contamination; D019317:Evidence-Based Medicine; D006801:Humans; D010289:Parenteral Nutrition, Total; D010689:Phlebitis / Q000209:etiology; D011446:Prospective Studies; D012189:Retrospective Studies; D012307:Risk Factors; D013924:Thrombophlebitis / Q000209:etiology; D013927:Thrombosis / Q000209:etiology; D013997:Time Factors
D000970:Antineoplastic Agents